Kinfo
Enveric Biosciences Inc. logo

Enveric Biosciences Inc.

ENVBNASDAQHealthcare·US · USD
$1.40
-0.06 (-4.11%)
Prices as of November 5, 2026 · market closed

Price

Key statistics

Valuation
Market cap6.45M USD
Enterprise value-1.81M USD
Trailing P/E0.00
Forward P/E-1.06
PEG ratio-0.00
Price / sales0.00
Price / book0.73
Profitability
Gross margin0.00%
Operating margin0.00%
Profit margin0.00%
Return on assets-87.34%
Return on equity-170.04%
Income (TTM)
Revenue0.00 USD
Gross profit0.00 USD
EBITDA-8.57M USD
Net income-12.09M USD
Diluted EPS-$13.01
Rev. growth (YoY)0.00%
Balance sheet
Total cash8.30M USD
Total debt0.00 USD
Debt / equity0.00
Current ratio10.21
Book value / share$2.05
Cash flow (TTM)
Operating cash flow-8.56M USD
Levered free cash flow-5.20M USD
Shares & price
Shares outstanding3.94M
Float4.34M
Held by institutions12.03%
Beta1.21
50-day MA$1.45
200-day MA$2.01
52-week high$13.25
52-week low$1.17
Dividends
Forward rate
$0.00
Yield
0.00%
Payout ratio
0.00%
Frequency
Unknown
Earnings (EPS)
DateEst.ActualSurprise2026-04-302.032.68+32.02%2026-02-231.010.59−41.58%2025-09-231.232.36+91.87%2025-03-28-2.76-2.03+26.45%2024-11-14-93.60-43.20+53.85%
About Enveric Biosciences Inc.

Enveric Biosciences Inc. is a biotechnology company focused on developing neuroplastogenic small-molecule therapeutics for psychiatric and neurological disorders. The company’s current pipeline centers on novel compounds designed to promote neuroplasticity while avoiding hallucinogenic effects, with a particular emphasis on depression, anxiety, and addiction-related conditions. Its lead program, EB-003, is being developed as a next-generation therapeutic candidate, and the broader research platform includes proprietary chemical libraries and additional preclinical assets aimed at mental health indications. Enveric Biosciences works at the intersection of neuroscience, medicinal chemistry, and drug discovery, positioning itself within the evolving field of psychedelic-inspired and neuropsychiatric medicine. The company is headquartered in Cambridge, Massachusetts.

Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Joseph Edward Tucker Ph.D.
Employees
5
Headquarters
Cambridge, MA, United States

Frequently asked questions about Enveric Biosciences Inc.